Cronos Group Inc.
TSX:CRON.TO · Toronto Stock Exchange
-$0.01 today
Vol 0.20M · Avg 0.19M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
TSX:CRON.TO · Revenue to Net Income
Key Ratios
Analysis
$159.5M of revenue converted into -$2.1M of net income for the selected period. Gross margin is 42.7% and net margin is -5.2%, showing how much revenue survives after costs and taxes. EPS is $-0.00, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $149.2M +26.9% | $117.5M +35.0% | $87.0M -0.6% | $87.5M +36.7% | $64.0M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $87.5M +0.5% | $87.1M +15.8% | $75.2M +4.4% | $72.0M -11.7% | $81.5M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $61.7M +102.6% | $30.5M +156.3% | $11.9M -23.7% | $15.6M +189.3% | -$17.4M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 41.4% +15.5pp | 25.9% +12.3pp | 13.7% -4.1pp | 17.8% +45.0pp | -27.3% | 9.8% | 28.9% | 38.3% |
| Research & Development | $4.5M +7.1% | $4.2M -27.5% | $5.8M -56.0% | $13.3M -38.8% | $21.7M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $75.0M -2.3% | $76.7M -4.9% | $80.7M -20.6% | $101.6M -15.8% | $120.7M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $79.5M -25.6% | $106.9M +10.8% | $96.5M -24.6% | $128.0M -53.0% | $272.1M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $14.5M +63.8% | $8.8M +18.9% | $7.4M -35.4% | $11.5M -13.7% | $13.4M | $374.2M | $1.2B | $631.8M |
| EBITDA | -$2.9M +93.5% | -$45.4M +37.2% | -$72.3M +23.0% | -$93.8M +37.8% | -$150.8M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -2.0% +36.6pp | -38.6% +44.4pp | -83.0% +24.1pp | -107.2% +128.4pp | -235.5% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$17.8M +76.7% | -$76.5M +9.6% | -$84.6M +24.8% | -$112.4M +61.2% | -$289.5M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -12.0% +53.1pp | -65.1% +32.1pp | -97.2% +31.2pp | -128.4% +323.8pp | -452.2% | 16.6% | 24.1% | 22.0% |
| Interest Income | $40.7M -17.9% | $49.5M -4.9% | $52.1M +138.4% | $21.8M +144.9% | $8.9M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $419.2K -99.6% | $113.0M +917.7% | $11.1M +214.9% | -$9.7M -106.0% | $162.1M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$17.4M -147.7% | $36.6M +149.7% | -$73.5M +39.8% | -$122.1M +4.2% | -$127.4M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -11.7% -42.8pp | 31.1% +115.5pp | -84.4% +55.0pp | -139.5% +59.6pp | -199.1% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | -$14.4M -320.2% | -$3.4M -6.4% | -$3.2M -109.4% | $34.5M +8168.3% | -$427.4K | $1.3B | -$1.6B | $745.2M |
| Net Income | -$9.6M -123.4% | $41.0M +155.6% | -$73.8M +56.7% | -$170.3M +56.7% | -$392.8M | $4.9B | $4.8B | $4.7B |
| Net Margin | -6.4% -41.4pp | 34.9% +119.7pp | -84.8% +109.7pp | -194.5% +419.0pp | -613.5% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$0 -125.1% | $0 +155.6% | -$0 +57.1% | -$0 -23.5% | -$0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$0 -125.1% | $0 +155.6% | -$0 +57.1% | -$0 -23.5% | -$0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $383.5M +0.3% | $382.2M +0.3% | $381.0M +2.9% | $370.4M +0.2% | $369.7M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $383.5M +0.3% | $382.2M +0.3% | $381.0M +2.9% | $370.4M +0.0% | $370.4M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector

Extendicare Inc.
TSX:EXE.TO
$3.20B
Trulieve Cannabis Corp.
TRUL.CN
$2.74B
Green Thumb Industries Inc.
GTII.CN
$2.49B

Sienna Senior Living Inc.
TSX:SIA.TO
$2.16B

WELL Health Technologies Corp.
TSX:WELL.TO
$1.12B

Knight Therapeutics Inc.
TSX:GUD.TO
$922.89M

Tilray Brands, Inc.
TSX:TLRY.TO
$794.17M
Verano Holdings Corp.
VRNO.NE
$593.56M
Cresco Labs Inc.
CL.CN
$403.82M
Rubicon Organics Inc.
ROMJ.V
$31.57M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does CRON.TO generate?
Cronos Group Inc. (CRON.TO) reported $149.15M of revenue in fiscal 2025.
Is CRON.TO profitable?
Cronos Group Inc. (CRON.TO) reported -$9,612,374.00 of net income, with a net margin of -6.4%.
Explore More
Continue the stock analysis
Jump to another research area for this company.